[1]
Mărginean CO, Mărginean MO, Simu I, Horvath A, Meliţ LE. Giant tubular adenoma with malignancy clinical characteristics in a female teenager: Case report and a review of the literature. Medicine. 2016 Oct:95(40):e4805. doi: 10.1097/MD.0000000000004805. Epub
[PubMed PMID: 27749532]
Level 3 (low-level) evidence
[3]
Bujanda L, Cosme A, Gil I, Arenas-Mirave JI. Malignant colorectal polyps. World journal of gastroenterology. 2010 Jul 7:16(25):3103-11
[PubMed PMID: 20593495]
[4]
Imperiale TF, Abhyankar PR, Stump TE, Emmett TW. Prevalence of Advanced, Precancerous Colorectal Neoplasms in Black and White Populations: A Systematic Review and Meta-analysis. Gastroenterology. 2018 Dec:155(6):1776-1786.e1. doi: 10.1053/j.gastro.2018.08.020. Epub 2018 Aug 22
[PubMed PMID: 30142339]
Level 1 (high-level) evidence
[5]
David Y, Ottaviano L, Park J, Iqbal S, Likhtshteyn M, Kumar S, Lyo H, Lewis AE, Lung BE, Frye JT, Huang L, Li E, Yang J, Martello L, Vignesh S, Miller JD, Follen M, Grossman EB. Confounders in Adenoma Detection at Initial Screening Colonoscopy: A Factor in the Assessment of Racial Disparities as a Risk for Colon Cancer. Journal of cancer therapy. 2019 Apr:10(4):269-289. doi: 10.4236/jct.2019.104022. Epub 2019 Apr 9
[PubMed PMID: 31032142]
[6]
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011 Mar-Apr:61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4
[PubMed PMID: 21296855]
[7]
Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, Doubeni C, Fireman BH, Quesenberry CP. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013 Feb:11(2):172-80. doi: 10.1016/j.cgh.2012.09.010. Epub 2012 Sep 14
[PubMed PMID: 22985608]
Level 2 (mid-level) evidence
[8]
Steele SR, Johnson EK, Champagne B, Davis B, Lee S, Rivadeneira D, Ross H, Hayden DA, Maykel JA. Endoscopy and polyps-diagnostic and therapeutic advances in management. World journal of gastroenterology. 2013 Jul 21:19(27):4277-88. doi: 10.3748/wjg.v19.i27.4277. Epub
[PubMed PMID: 23885138]
Level 3 (low-level) evidence
[9]
Paggi S, Radaelli F, Repici A, Hassan C. Advances in the removal of diminutive colorectal polyps. Expert review of gastroenterology & hepatology. 2015 Feb:9(2):237-44. doi: 10.1586/17474124.2014.950955. Epub 2014 Aug 26
[PubMed PMID: 25155348]
Level 3 (low-level) evidence
[10]
Gibson JA, Odze RD. Pathology of premalignant colorectal neoplasia. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2016 Apr:28(3):312-23. doi: 10.1111/den.12633. Epub 2016 Mar 15
[PubMed PMID: 26861656]
[11]
Andrade DO, Ferreira AR, Bittencourt PF, Ribeiro DF, Silva RG, Alberti LR. CLINICAL, EPIDEMIOLOGIC, AND ENDOSCOPIC PROFILE IN CHILDREN AND ADOLESCENTS WITH COLONIC POLYPS IN TWO REFERENCE CENTERS. Arquivos de gastroenterologia. 2015 Dec:52(4):303-10. doi: 10.1590/S0004-28032015000400010. Epub
[PubMed PMID: 26840472]
[12]
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FAR, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Owens DK, Phillips WR, Phipps MG, Pignone MP, Siu AL. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016 Jun 21:315(23):2564-2575. doi: 10.1001/jama.2016.5989. Epub
[PubMed PMID: 27304597]
[13]
Jover R, Dekker E, Schoen RE, Hassan C, Pellise M, Ladabaum U, WEO Expert Working Group of Surveillance after colonic neoplasm. Colonoscopy quality requisites for selecting surveillance intervals: A World Endoscopy Organization Delphi Recommendation. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2018 Nov:30(6):750-759. doi: 10.1111/den.13229. Epub 2018 Jul 26
[PubMed PMID: 29971834]
Level 2 (mid-level) evidence
[14]
Tanaka S, Saitoh Y, Matsuda T, Igarashi M, Matsumoto T, Iwao Y, Suzuki Y, Nishida H, Watanabe T, Sugai T, Sugihara K, Tsuruta O, Hirata I, Hiwatashi N, Saito H, Watanabe M, Sugano K, Shimosegawa T, Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for management of colorectal polyps. Journal of gastroenterology. 2015 Mar:50(3):252-60. doi: 10.1007/s00535-014-1021-4. Epub 2015 Jan 7
[PubMed PMID: 25559129]
Level 1 (high-level) evidence
[15]
Kang H, Thoufeeq MH. Size of colorectal polyps determines time taken to remove them endoscopically. Endoscopy international open. 2018 May:6(5):E610-E615. doi: 10.1055/a-0587-4681. Epub 2018 May 8
[PubMed PMID: 29756019]
[16]
Patil R, Ona MA, Ofori E, Reddy M. Endocuff-Assisted Colonoscopy-A Novel Accessory in Improving Adenoma Detection Rate: A Review of the Literature. Clinical endoscopy. 2016 Nov:49(6):533-538
[PubMed PMID: 27133962]
[17]
Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK. Pseudopolyps in inflammatory bowel diseases: Have we learned enough? World journal of gastroenterology. 2017 Mar 7:23(9):1541-1551. doi: 10.3748/wjg.v23.i9.1541. Epub
[PubMed PMID: 28321155]
[18]
Jelsig AM. Hamartomatous polyps - a clinical and molecular genetic study. Danish medical journal. 2016 Aug:63(8):. pii: B5280. Epub
[PubMed PMID: 27477802]
[19]
Campos FG. Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World journal of gastroenterology. 2014 Nov 28:20(44):16620-9. doi: 10.3748/wjg.v20.i44.16620. Epub
[PubMed PMID: 25469031]
[20]
Kalady MF, Jarrar A, Leach B, LaGuardia L, O'Malley M, Eng C, Church JM. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Diseases of the colon and rectum. 2011 Feb:54(2):164-70. doi: 10.1007/DCR.0b013e3181fd4c15. Epub
[PubMed PMID: 21228663]
[21]
Leoz ML, Carballal S, Moreira L, Ocaña T, Balaguer F. The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. The application of clinical genetics. 2015:8():95-107. doi: 10.2147/TACG.S51484. Epub 2015 Apr 16
[PubMed PMID: 25931827]
[22]
Dipro S, Al-Otaibi F, Alzahrani A, Ulhaq A, Al Shail E. Turcot syndrome: a synchronous clinical presentation of glioblastoma multiforme and adenocarcinoma of the colon. Case reports in oncological medicine. 2012:2012():720273. doi: 10.1155/2012/720273. Epub 2012 Oct 16
[PubMed PMID: 23119205]
Level 3 (low-level) evidence
[23]
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. Journal of the National Cancer Institute. 2013 Nov 6:105(21):1607-16. doi: 10.1093/jnci/djt277. Epub 2013 Oct 17
[PubMed PMID: 24136893]
Level 1 (high-level) evidence
[24]
Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, Bertario L, Blanco I, Bülow S, Burn J, Capella G, Colas C, Friedl W, Møller P, Hes FJ, Järvinen H, Mecklin JP, Nagengast FM, Parc Y, Phillips RK, Hyer W, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen JT, Clark SK, Hodgson SV. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010 Jul:59(7):975-86. doi: 10.1136/gut.2009.198499. Epub
[PubMed PMID: 20581245]
Level 1 (high-level) evidence
[25]
Yuan W, Tian L, Ai FY, Liu SJ, Shen SR, Wang XY, Liu F. Cronkhite-Canada syndrome: A case report. Oncology letters. 2018 Jun:15(6):8447-8453. doi: 10.3892/ol.2018.8409. Epub 2018 Apr 2
[PubMed PMID: 29805581]
Level 3 (low-level) evidence
[26]
Sant V, Reich E, Khanna L, Cao W, Kornacki S, Grucela A. Attenuated familial adenomatous polyposis (AFAP) in a patient associated with a novel mutation in APC. BMJ case reports. 2019 Nov 10:12(11):. doi: 10.1136/bcr-2019-231232. Epub 2019 Nov 10
[PubMed PMID: 31712236]
Level 3 (low-level) evidence
[27]
O'Connell BM, Crockett SD. The clinical impact of serrated colorectal polyps. Clinical epidemiology. 2017:9():113-125. doi: 10.2147/CLEP.S106257. Epub 2017 Feb 22
[PubMed PMID: 28260946]
[28]
Saraste D, Martling A, Nilsson PJ, Blom J, Törnberg S, Hultcrantz R, Janson M. Complications after colonoscopy and surgery in a population-based colorectal cancer screening programme. Journal of medical screening. 2016 Sep:23(3):135-40. doi: 10.1177/0969141315625701. Epub 2016 Mar 2
[PubMed PMID: 26940962]
[29]
Zwink N, Holleczek B, Stegmaier C, Hoffmeister M, Brenner H. Complication Rates in Colonoscopy Screening for Cancer. Deutsches Arzteblatt international. 2017 May 5:114(18):321-327. doi: 10.3238/arztebl.2017.0321. Epub
[PubMed PMID: 28587708]